Your browser doesn't support javascript.
loading
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar, Manoj V; Bhatnagar, Tarun; Selvaraju, Sriram; Saravanakumar, V; Thangaraj, Jeromie Wesley Vivian; Shah, Naman; Kumar, Muthusamy Santhosh; Rade, Kiran; Sabarinathan, R; Asthana, Smita; Balachandar, Rakesh; Bangar, Sampada Dipak; Bansal, Avi Kumar; Bhat, Jyothi; Chopra, Vishal; Das, Dasarathi; Deb, Alok Kumar; Devi, Kangjam Rekha; Dwivedi, Gaurav Raj; Khan, S Muhammad Salim; Kumar, C P Girish; Kumar, M Sunil; Laxmaiah, Avula; Madhukar, Major; Mahapatra, Amarendra; Mohanty, Suman Sundar; Rangaraju, Chethana; Turuk, Alka; Baradwaj, Dinesh Kumar; Chahal, Ashrafjit S; Debnath, Falguni; Haq, Inaamul; Kalliath, Arshad; Kanungo, Srikanta; Kshatri, Jaya Singh; Lakshmi, G G J Naga; Mitra, Anindya; Nirmala, A R; Prasad, Ganta Venkata; Qurieshi, Mariya Amin; Sahay, Seema; Sangwan, Ramesh Kumar; Sekar, Krithikaa; Shukla, Vijay Kumar; Singh, Prashant Kumar; Singh, Pushpendra; Singh, Rajeev; Varma, Dantuluri Sheethal; Viramgami, Ankit; Panda, Samiran.
Afiliação
  • Murhekar MV; Indian Council of Medical Research (ICMR) National Institute of Epidemiology, Chennai, India. Electronic address: mmurhekar@gmail.com.
  • Bhatnagar T; Indian Council of Medical Research (ICMR) National Institute of Epidemiology, Chennai, India.
  • Selvaraju S; ICMR National Institute for Research in Tuberculosis, Chennai, India.
  • Saravanakumar V; Indian Council of Medical Research (ICMR) National Institute of Epidemiology, Chennai, India.
  • Thangaraj JWV; Indian Council of Medical Research (ICMR) National Institute of Epidemiology, Chennai, India.
  • Shah N; Indian Council of Medical Research (ICMR) National Institute of Epidemiology, Chennai, India.
  • Kumar MS; Indian Council of Medical Research (ICMR) National Institute of Epidemiology, Chennai, India.
  • Rade K; WHO Country Office for India, New Delhi, India.
  • Sabarinathan R; Indian Council of Medical Research (ICMR) National Institute of Epidemiology, Chennai, India.
  • Asthana S; ICMR National Institute of Cancer Prevention and Research, Noida, India.
  • Balachandar R; ICMR National Institute of Occupational Health, Ahmedabad, India.
  • Bangar SD; ICMR National AIDS Research Institute, Pune, India.
  • Bansal AK; ICMR National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, India.
  • Bhat J; ICMR National Institute of Research in Tribal Health, Jabalpur, India.
  • Chopra V; State Tuberculosis Training, Demonstration Centre (STDC), Punjab, India.
  • Das D; ICMR Regional Medical Research Centre, Bhubaneswar, India.
  • Deb AK; ICMR National Institute of Cholera and Enteric Diseases, Kolkata, India.
  • Devi KR; ICMR Regional Medical Research Centre, Northeast Region, Dibrugarh, India.
  • Dwivedi GR; ICMR Regional Medical Research Centre, Gorakhpur, India.
  • Khan SMS; Department of Community Medicine, Government Medical College, Srinagar, India.
  • Kumar CPG; Indian Council of Medical Research (ICMR) National Institute of Epidemiology, Chennai, India.
  • Kumar MS; STDC, Thiruvananthapuram, India.
  • Laxmaiah A; ICMR National Institute of Nutrition, Hyderabad, India.
  • Madhukar M; ICMR Rajendra Memorial Research Institute of Medical Sciences, Patna, India.
  • Mahapatra A; ICMR Regional Medical Research Centre, Bhubaneswar, India.
  • Mohanty SS; ICMR National Institute for Implementation Research on Non-Communicable Diseases, Jodhpur, India.
  • Rangaraju C; National Tuberculosis Institute, Bangalore, India.
  • Turuk A; ICMR, New Delhi, India.
  • Baradwaj DK; ICMR National Institute of Nutrition, Hyderabad, India.
  • Chahal AS; State Tuberculosis Training, Demonstration Centre (STDC), Punjab, India.
  • Debnath F; ICMR National Institute of Cholera and Enteric Diseases, Kolkata, India.
  • Haq I; Department of Community Medicine, Government Medical College, Srinagar, India.
  • Kalliath A; STDC, Thiruvananthapuram, India.
  • Kanungo S; ICMR Regional Medical Research Centre, Bhubaneswar, India.
  • Kshatri JS; ICMR Regional Medical Research Centre, Bhubaneswar, India.
  • Lakshmi GGJN; Office of Joint Director for Tuberculosis, Directorate of Public Health and Family Welfare, Andhra Pradesh, India.
  • Mitra A; STDC, Jharkhand, India.
  • Nirmala AR; Lady Willingdon State Tuberculosis Centre, Government of Karnataka, Bengaluru, India.
  • Prasad GV; Office of Joint Director for Tuberculosis, Directorate of Public Health and Family Welfare, Andhra Pradesh, India.
  • Qurieshi MA; Department of Community Medicine, Government Medical College, Srinagar, India.
  • Sahay S; ICMR National AIDS Research Institute, Pune, India.
  • Sangwan RK; ICMR National Institute for Implementation Research on Non-Communicable Diseases, Jodhpur, India.
  • Sekar K; ICMR National Institute for Research in Tuberculosis, Chennai, India.
  • Shukla VK; Directorate Health Services, Raipur, India.
  • Singh PK; ICMR National Institute of Cancer Prevention and Research, Noida, India.
  • Singh P; ICMR National Institute of Research in Tribal Health, Jabalpur, India.
  • Singh R; ICMR Regional Medical Research Centre, Gorakhpur, India.
  • Varma DS; Office of Joint Director for Tuberculosis, Directorate of Public Health and Family Welfare, Andhra Pradesh, India.
  • Viramgami A; ICMR National Institute of Occupational Health, Ahmedabad, India.
  • Panda S; ICMR, New Delhi, India.
Lancet Glob Health ; 9(3): e257-e266, 2021 03.
Article em En | MEDLINE | ID: mdl-33515512
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Lancet Glob Health Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Lancet Glob Health Ano de publicação: 2021 Tipo de documento: Article